Two members of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party sent letters to the CEO's of TikTok, Apple, and Google, reminding them of their need to comply with the recent court ruling that upheld the ban against TikTok.
French President Emmanuel Macron has appointed centrist François Bayrou as the country’s new prime minister, marking the fourth person to hold the role in just one year. This appointment comes after Prime Minister Michel Barnier’s government collapsed following a no-confidence vote in the National Assembly due to deadlock over France’s 2025 budget.
With fewer than 40 days until Inauguration Day, President-elect Donald Trump is adjusting his approach to key campaign promises. While his “Promises Made, Promises Kept” mantra energized his base throughout the 2024 campaign, Trump is now striking a more tempered tone on major issues like inflation, foreign policy, and government spending.
A shocking claim has emerged from Tom Cullerton, a disabled veteran and seasoned federal employee, who alleges political persecution, retaliation, and discrimination within the United States Department of Agriculture (USDA) and U.S. Forest Service (USFS). Speaking exclusively to The Gateway Pundit, Cullerton detailed a troubling pattern of Hatch Act violations, partisan rhetoric, and a hostile work environment.
Former California Gov. Jerry Brown (D) expressed concern on Thursday that the state has exceeded the original intent of the sanctuary law he signed during his tenure. In an interview with Sacramento’s ABC10, Brown remarked that cities like San Francisco have taken sanctuary policies to an extreme, creating a near-complete separation between state and federal immigration enforcement.
House Speaker Mike Johnson (R-LA) is preparing to unveil a government spending bill that could include key components of President-elect Donald Trump’s healthcare agenda. Among the priorities under consideration is reforming Pharmacy Benefit Manager (PBM) practices, a move aimed at lowering prescription drug costs for seniors by tackling middleman-driven price inflation.